Also known as LBH589, Farydak®, LBH-589, LBH 589, (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide
Panobinostat, sold under the brand name Farydak, is a medication used for the treatment of multiple myeloma. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor).
via PubMed
~6 min read
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 455315413 | image = Panobinostat.svg | image_class = skin-invert-image | width = 275 | alt =
| pronounce = | tradename = Farydak | Drugs.com = | DailyMedID = Panobinostat | pregnancy_AU = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = XH03 | ATC_supplemental =
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).